Latest Observability News

Peak Rare Earths has secured court approval for its acquisition by Shenghe Resources, marking a pivotal moment with shares set to suspend and delist soon. Shareholders will receive $0.443 per share as the scheme moves toward completion.

Echo IQ has completed its presentation to the CPT Editorial Panel for a Category III CPT code for EchoSolv AS, with a decision expected from the American Medical Association in the coming weeks. Meanwhile, the company is advancing US deployments and FDA clearance efforts.

Following its recent sale transaction, MPR Australia Limited announces significant board resignations alongside continued leadership under CEO Nathan Wise, signaling a strategic transition phase.

Atlas Arteria has announced an ordinary dividend of AUD 0.20 per security for the six months ending June 2025, payable in early October. The dividend is fully unfranked, reflecting the company’s international income streams.

American Uranium Limited is set to commence hydrogeologic testing and resource expansion drilling at its Lo Herma uranium project in Wyoming during the fourth quarter of 2025, aiming to boost its mineral resource base and support upcoming scoping studies.

Resolution Minerals Ltd has successfully raised $25.1 million through a heavily supported placement, positioning itself to advance its Horse Heaven Project in Idaho and prepare for a NASDAQ listing.

Tempest Minerals has secured regulatory approval to begin Phase I drilling at its Halo prospect within the Yalgoo Project, targeting iron, copper, and gold. A heritage survey with the Badimia People is currently in progress, marking a key step toward unlocking the site's potential.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

OncoSil Medical’s PANCOSIL Phase 1-2 study reveals promising safety and feasibility for a novel CT-guided pancreatic cancer therapy, with survival outcomes exceeding historical benchmarks.

Canterbury Resources has extended its 2025 Share Purchase Plan to 22 October, aiming to raise $0.75 million to advance exploration at its Jack Shay, Peenam, and Briggs copper projects.

Lord Resources has visually confirmed a significant 20.2-metre copper mineralisation interval at its Ilgarari Copper Project in Western Australia, highlighting promising signs of a supergene-enriched zone. Assay results are expected in October as drilling continues.

Greenvale Energy’s latest assays from its maiden drilling at the Oasis Uranium Project reveal continuous, near-surface high-grade uranium mineralisation, reinforcing the project’s promising potential.